Home > All articles > Medaffcon answers call for its solutions-oriented data approach in Sweden
Medaffcon answers call for its solutions-oriented data approach in Sweden
The Finnish pioneer in identifying and compiling relevant data for pharmaceutical research projects broadens its in-house expertise to also cover Swedish healthcare registries, to provide customers access to an even larger trove of high-quality healthcare data.
Medaffcon has added Swedish healthcare registries to its capabilities as it continues to pursue growth and facilitate data utilisation by providing pharmaceutical companies access to rich and relevant healthcare data.
CEO Jarmo Hahl says the expansion aligns with the needs of both the company and its customers.
It allows the company to continue growing and increase the amount of high-quality digital healthcare data it can sift through to collate datasets and analyses that satisfy the specific needs of each pharmaceutical research project.
“The Nordic market is growing, and you have to be there to succeed,” he states. “Sweden is also the main market for many pharmaceutical companies.”
“Customers can be confident that they’ll have access to our familiar and solutions-oriented model of operation also in Sweden.”
The primary impetus for the expansion, however, was the desire of many customers to combine healthcare data from registries across the Nordics – and accomplish this as flexibly and cost-efficiently as possible.
“Medaffcon wants to respond to that demand and offer in-house expertise in Sweden. Customers can be confident that they’ll have access to our familiar and solutions-oriented model of operation also in Sweden,” promises Hahl.
This bodes well also – and most importantly – for patients. By drawing from a larger pool of healthcare data, pharmaceutical companies can target, develop and launch their products more precisely for certain diseases and patient groups, potentially resulting in safer and more personalised pharmacotherapies.
“As medications today are introduced for increasingly specific diseases and populations, our capacity to plan and execute studies is better when we can combine data from various countries,” explains Dr. Mariann Lassenius, the real-world evidence lead at Medaffcon.
Moving data from Sweden to Finland can be done securely, and the data can be combined for valuable analyses without regulatory restrictions, she points out.
Swedish data is readily available for research and innovation
Medaffcon has recruited Dr. Johanna Simin, a clinical epidemiologist with a PhD from the Karolinska Institute in Stockholm, as its lead real-world epidemiologist in Sweden. Dr. Simin has used Swedish national and disease-specific health and administrative data registries in numerous large-scale research projects for the past decade, building not only her expertise of healthcare data but also an extensive network of contacts in Sweden.
Sweden’s high-quality healthcare system, she tells, offers comprehensive longitudinal patient-oriented data registries, valid data linkage possibilities and simply a vast amount of readily available data.
“The climate is also fairly supportive of research and innovation,” she adds. “Once you satisfy with the regulatory requirements, the data become available.”
“The Nordics, with their exceptional data sources and infrastructure, are clear forerunners in the real-world data and evidence landscape. I’m thrilled that we can now provide state-of-the-art real-world evidence solutions in both Finland and Sweden, to Medaffcon’s new and present customers,” says Dr. Simin.
“Sweden’s high-quality healthcare system offers a vast amount of readily available data.”
By leveraging its access and understanding of the high-quality healthcare services, massive digital data repositories and research-supportive operating environment in the Nordics, Medaffcon is uniquely positioned to be a reliable and valuable partner for organisations eager to utilise healthcare data for research and product development.
Dr Johanna Simin joined Medaffcon in May 2023. She is a trained epidemiologist based in Sweden. She obtained her master’s and doctoral degrees from Karolinska Institutet, Stockholm, where she continued her work as a post-doctoral researcher focusing mainly on the long-term effects of prescription drugs. Her international projects have been based on high-quality Swedish health data registries, many of the cohorts being globally among the largest. She has broad experience in international collaborations between leading universities and pharmaceutical companies and has supervised postgraduate students nationally and internationally. “What drives me is the purpose of my work – I believe in enhancing health with big data. Here, the Nordics offer incomparable real-world possibilities”.
Mariann joined Medaffcon’s team in 2016 after finishing her PhD. The transition to real world evidence (RWE) research was a natural continuum to her previous research career. Through RWE studies, she has had the privilege to gain a broad insight into working with different stakeholders within the healthcare field. The vast proportion of her days goes towards interacting with clients, planning and performing RWE studies, and supporting Medaffcon’s RWE team. Subjects that keep her work interesting are the vast variability of customers and projects, problem-solving, and interacting with people.
“The number of RWE studies has increased since stakeholders within the healthcare industry have an increasing demand for knowledge-based decision making tools that need to be fulfilled. The future, therefore, has an ever-increasing emphasis on RWE”.